White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down._老虎社区_美港股上老虎

White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.

Barron's2021-09-09

The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal. The plan will allow Medicare to ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

202

Bull1973
·2021-09-10
Yes
回复
3
举报
收起
- EmChung:
  👍🏼
  2021-09-14
  回复
  举报
KH321
·2021-09-10
OK
回复
4
举报
收起
- Bull1973:
  Yes
  2021-09-10
  回复
  举报
LST3
·2021-09-10
Good
回复
2
举报
SPOT_ON
·2021-09-10
Like n follow
回复
7
举报
收起
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-09-10
  回复
  举报
- SPOT_ON:
  👍
  2021-09-10
  回复
  举报
blackblack1
·2021-09-10
Pls like
回复
6
举报
收起
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-09-10
  回复
  举报
- joyciology:
  done
  2021-09-10
  回复
  举报
- DMC8:
  Okay ✅
  2021-09-10
  回复
  举报
Rdhilly
·2021-09-10
.
回复
7
举报
HENRYCSC
·2021-09-09
Good
回复
2
举报
CIG
·2021-09-09
Need fine tuning, can't fix without delicate rulings.
回复
3
举报
GeraldHere
·2021-09-09
Hi
回复
4
举报
Alfred1007
·2021-09-09
This put pharma companies in dilemma, if you spend billions but your drug can't bring much profit, the risk vs reward doesn't pay off...it is a good intention, but need to strike a balance.
回复
6
举报
收起
- LohYK:
  that why the price flux are so extreme
  2021-09-09
  回复
  举报
- joshc:
  yes, and if there is such price negotiation (manipulation??) then isn't it harder for pharma coys to determine what is their revenue going to be when they are first developing the drug?
  2021-09-10
  回复
  举报
chaicka
·2021-09-09
Yet on the flip side, there are decades old drugs which are getting ridiculously expensive. E.g. Panadol is now so expensive when it is not a new drug at all. Maybe the policy needs some kind of tweaking such as ‘applicable to drugs which have been release for >5 years, including any minor revisions to the same drug’.
回复
5
举报
收起
- koolgal:
  Yes Panadol is very expensive in Singapore. 🤔
  2021-09-23
  回复
  举报
- ALearner:
  Panadol is a generic drug, the poliCy wikl imPact proprietary drug the most i guess
  2021-09-10
  回复
  举报
- chaicka:
  I know cause i worked in Pharma firm before. What i meant is old drugs that have been around for 20-40 years have already recoup R&D costs yet retail price keep increase is not right.
  2021-09-09
  回复
  举报
查看更多 2 条评论
AxelOng
·2021-09-09
If u control the price there will be not motivation to spend money in r n d. No good for research
回复
5
举报
收起
- JamesArthur:
  Agree to the max
  2021-09-09
  回复
  举报
Wheee
·2021-09-09
Like
回复
6
举报
收起
- D199991D:
  Done
  2021-09-09
  回复
  举报
- JeremyKok:
  hi. please like and comment back. thank you.
  2021-09-10
  回复
  举报
SiewWeng
·2021-09-09
Yay
回复
5
举报
Ygh
·2021-09-09
Hi
回复
6
举报
收起
- SiewWeng:
  Hey
  2021-09-09
  回复
  举报
firstfruits
·2021-09-09
generic and biosimilar should be advantaged by this policy
回复
5
举报
收起
- joshc:
  generics and biosimilar makers FTW
  2021-09-10
  回复
  举报
Gyawh
·2021-09-09
hi
回复
8
举报
Gladys12345
·2021-09-09
Please like
回复
8
举报
收起
- Wheee:
  ok
  2021-09-09
  回复
  举报
- St1143:
  Done
  2021-09-09
  回复
  举报
- HueiKwang:
  Liked
  2021-09-09
  回复
  举报
查看更多 1 条评论
Bll
·2021-09-09
Like pls
回复
10
举报
收起
- Ygh:
  Done
  2021-09-09
  回复
  举报
- Gladys12345:
  Please like
  2021-09-09
  回复
  举报
Degenerated
·2021-09-09
Drop more. I want to buu pfizer
回复
7
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-09-09 22:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176976417","market":"us","top_or_hot":-1,"title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.","media":"Barron's","content":"<div>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to ...\n\n<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">网页链接</a>\n\n</div>\n","source":"lsy1610680873436","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews>Barron's</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to ...\n\n<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","article_id":"1176976417","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","pubTimestamp":1631197026,"columns":[],"sourceInfo":{"source_id":"lsy1610680873436","name":"Barron's"},"weMediaInfo":null,"summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","collect":0,"end_time":0,"defaultTopTitle":"marketwatch.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"translate_title":"《华尔街日报》称，白宫将宣布药品定价计划。制药股下跌。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9},"content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":883147957,"gmtCreate":1631230140879,"gmtModify":1631890034828,"author":{"id":"3584680402793671","authorId":"3584680402793671","name":"Bull1973","avatar":"https://static.tigerbbs.com/866d29bf88ff7363d121a5ccc6028aae","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3584680402793671","authorIdStr":"3584680402793671"},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883147957","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5867978,"gmtCreate":1631633075577,"gmtModify":1631890034831,"authorId":3566723689439669,"author":{"id":3566723689439669,"idStr":"3566723689439669","authorId":3566723689439669,"name":"EmChung","avatar":"https://static.tigerbbs.com/99db9b9b2d5d303db43970c31a6ba528","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883147957,"type":1,"supId":0,"prevId":0,"content":"👍🏼","text":"👍🏼","html":"👍🏼"}],"langContent":"EN"},{"id":883132949,"gmtCreate":1631224493981,"gmtModify":1631889939013,"author":{"id":"3586451610703869","authorId":"3586451610703869","name":"KH321","avatar":"https://static.tigerbbs.com/c1bb8bd7d6d5df5f9732871fe60999ea","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586451610703869","authorIdStr":"3586451610703869"},"htmlText":"OK&nbsp;","listText":"OK&nbsp;","text":"OK","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883132949","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5811122,"gmtCreate":1631230149003,"gmtModify":1631889939013,"authorId":3584680402793671,"author":{"id":3584680402793671,"idStr":"3584680402793671","authorId":3584680402793671,"name":"Bull1973","avatar":"https://static.tigerbbs.com/866d29bf88ff7363d121a5ccc6028aae","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883132949,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"}],"langContent":"EN"},{"id":883197549,"gmtCreate":1631223252281,"gmtModify":1631891709745,"author":{"id":"3576578158811365","authorId":"3576578158811365","name":"LST3","avatar":"https://static.tigerbbs.com/5ebefe56c7d81742050e1a8d5a94ef9a","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3576578158811365","authorIdStr":"3576578158811365"},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883197549","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883194676,"gmtCreate":1631222986895,"gmtModify":1632883907748,"author":{"id":"3582922989777578","authorId":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3582922989777578","authorIdStr":"3582922989777578"},"htmlText":"Like n follow","listText":"Like n follow","text":"Like n follow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883194676","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5810854,"gmtCreate":1631229064386,"gmtModify":1634804033360,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883194676,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."},{"id":5811041,"gmtCreate":1631229886728,"gmtModify":1634804015301,"authorId":3582922989777578,"author":{"id":3582922989777578,"idStr":"3582922989777578","authorId":3582922989777578,"name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883194676,"type":1,"supId":5810854,"prevId":0,"content":"👍","text":"👍","html":"👍"}],"langContent":"EN"},{"id":883191131,"gmtCreate":1631221947123,"gmtModify":1631889881594,"author":{"id":"4087735305621010","authorId":"4087735305621010","name":"blackblack1","avatar":"https://static.tigerbbs.com/77a3f9b815b90862b1826692953a69dd","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087735305621010","authorIdStr":"4087735305621010"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/883191131","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5810857,"gmtCreate":1631229086641,"gmtModify":1631889881622,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883191131,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."},{"id":5810268,"gmtCreate":1631225152948,"gmtModify":1631889881610,"authorId":3582108671334900,"author":{"id":3582108671334900,"idStr":"3582108671334900","authorId":3582108671334900,"name":"joyciology","avatar":"https://static.tigerbbs.com/bd90c4b20dfdf9210ef5daec9af84af3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883191131,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"},{"id":5810050,"gmtCreate":1631222417400,"gmtModify":1631889881598,"authorId":3579992296424941,"author":{"id":3579992296424941,"idStr":"3579992296424941","authorId":3579992296424941,"name":"DMC8","avatar":"https://static.tigerbbs.com/65aa8f5f6299558ce2ab36482793f750","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883191131,"type":1,"supId":0,"prevId":0,"content":"Okay ✅","text":"Okay ✅","html":"Okay ✅"}],"langContent":"EN"},{"id":883190528,"gmtCreate":1631220204964,"gmtModify":1632883914426,"author":{"id":"3576861864918846","authorId":"3576861864918846","name":"Rdhilly","avatar":"https://static.tigerbbs.com/d00424543e3f5db74636158d0166cd42","vip":1,"crmLevel":12,"crmLevelSwitch":0,"idStr":"3576861864918846","authorIdStr":"3576861864918846"},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883190528","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883310561,"gmtCreate":1631201107353,"gmtModify":1632883960393,"author":{"id":"3575091428590185","authorId":"3575091428590185","name":"HENRYCSC","avatar":"https://static.tigerbbs.com/6d47a6dec25b21dc547a5b982674c499","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3575091428590185","authorIdStr":"3575091428590185"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883310561","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883338810,"gmtCreate":1631200693830,"gmtModify":1632883965055,"author":{"id":"3583974841960176","authorId":"3583974841960176","name":"CIG","avatar":"https://static.tigerbbs.com/6c2077e2370e1ffcaca7e29b875be2be","vip":1,"crmLevel":12,"crmLevelSwitch":0,"idStr":"3583974841960176","authorIdStr":"3583974841960176"},"htmlText":"Need fine tuning, can't fix without delicate rulings.","listText":"Need fine tuning, can't fix without delicate rulings.","text":"Need fine tuning, can't fix without delicate rulings.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883338810","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883399484,"gmtCreate":1631199792848,"gmtModify":1632883973921,"author":{"id":"3557488303457204","authorId":"3557488303457204","name":"GeraldHere","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3557488303457204","authorIdStr":"3557488303457204"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883399484","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883309204,"gmtCreate":1631199173008,"gmtModify":1632883980071,"author":{"id":"3570656625926041","authorId":"3570656625926041","name":"Alfred1007","avatar":"https://static.tigerbbs.com/81d8406380cbc0525927f00a9510f2fa","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3570656625926041","authorIdStr":"3570656625926041"},"htmlText":"This put pharma companies in dilemma, if you spend billions but your drug can't bring much profit, the risk vs reward doesn't pay off...it is a good intention, but need to strike a balance.","listText":"This put pharma companies in dilemma, if you spend billions but your drug can't bring much profit, the risk vs reward doesn't pay off...it is a good intention, but need to strike a balance.","text":"This put pharma companies in dilemma, if you spend billions but your drug can't bring much profit, the risk vs reward doesn't pay off...it is a good intention, but need to strike a balance.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883309204","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5808558,"gmtCreate":1631199456773,"gmtModify":1634804209280,"authorId":3568070265339857,"author":{"id":3568070265339857,"idStr":"3568070265339857","authorId":3568070265339857,"name":"LohYK","avatar":"https://static.tigerbbs.com/d6add0343094f5e965e831fa432314ef","vip":1,"crmLevel":13,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883309204,"type":1,"supId":0,"prevId":0,"content":"that why the price flux are so extreme","text":"that why the price flux are so extreme","html":"that why the price flux are so extreme"},{"id":5812843,"gmtCreate":1631235947463,"gmtModify":1634803851977,"authorId":3570623270313531,"author":{"id":3570623270313531,"idStr":"3570623270313531","authorId":3570623270313531,"name":"joshc","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883309204,"type":1,"supId":0,"prevId":0,"content":"yes, and if there is such price negotiation (manipulation??) then isn't it harder for pharma coys to determine what is their revenue going to be when they are first developing the drug?","text":"yes, and if there is such price negotiation (manipulation??) then isn't it harder for pharma coys to determine what is their revenue going to be when they are first developing the drug?","html":"yes, and if there is such price negotiation (manipulation??) then isn't it harder for pharma coys to determine what is their revenue going to be when they are first developing the drug?"}],"langContent":"EN"},{"id":883947999,"gmtCreate":1631198458211,"gmtModify":1631889735601,"author":{"id":"4090019857770890","authorId":"4090019857770890","name":"chaicka","avatar":"https://static.tigerbbs.com/c0c291a2a7983f128cf68e5b01fedd73","vip":1,"crmLevel":12,"crmLevelSwitch":0,"idStr":"4090019857770890","authorIdStr":"4090019857770890"},"htmlText":"Yet on the flip side, there are decades old drugs which are getting ridiculously expensive. E.g. Panadol is now so expensive when it is not a new drug at all. Maybe the policy needs some kind of tweaking such as ‘applicable to drugs which have been release for &gt;5 years, including any minor revisions to the same drug’.","listText":"Yet on the flip side, there are decades old drugs which are getting ridiculously expensive. E.g. Panadol is now so expensive when it is not a new drug at all. Maybe the policy needs some kind of tweaking such as ‘applicable to drugs which have been release for &gt;5 years, including any minor revisions to the same drug’.","text":"Yet on the flip side, there are decades old drugs which are getting ridiculously expensive. E.g. Panadol is now so expensive when it is not a new drug at all. Maybe the policy needs some kind of tweaking such as ‘applicable to drugs which have been release for >5 years, including any minor revisions to the same drug’.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/883947999","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5967590,"gmtCreate":1632367417651,"gmtModify":1634788419017,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883947999,"type":1,"supId":0,"prevId":0,"content":"Yes Panadol is very expensive in Singapore. 🤔","text":"Yes Panadol is very expensive in Singapore. 🤔","html":"Yes Panadol is very expensive in Singapore. 🤔"},{"id":5818011,"gmtCreate":1631264826558,"gmtModify":1631889735611,"authorId":3581627611317712,"author":{"id":3581627611317712,"idStr":"3581627611317712","authorId":3581627611317712,"name":"ALearner","avatar":"https://static.tigerbbs.com/dd4e09038044887c08337f0d263b9446","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883947999,"type":1,"supId":0,"prevId":0,"content":"Panadol is a generic drug, the poliCy wikl imPact proprietary drug the most i guess ","text":"Panadol is a generic drug, the poliCy wikl imPact proprietary drug the most i guess ","html":"Panadol is a generic drug, the poliCy wikl imPact proprietary drug the most i guess "},{"id":5809027,"gmtCreate":1631201558166,"gmtModify":1631889735600,"authorId":4090019857770890,"author":{"id":4090019857770890,"idStr":"4090019857770890","authorId":4090019857770890,"name":"chaicka","avatar":"https://static.tigerbbs.com/c0c291a2a7983f128cf68e5b01fedd73","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883947999,"type":1,"supId":5808847,"prevId":0,"content":"I know cause i worked in Pharma firm before. What i meant is old drugs that have been around for 20-40 years have already recoup R&amp;D costs yet retail price keep increase is not right.","text":"I know cause i worked in Pharma firm before. What i meant is old drugs that have been around for 20-40 years have already recoup R&amp;D costs yet retail price keep increase is not right.","html":"I know cause i worked in Pharma firm before. What i meant is old drugs that have been around for 20-40 years have already recoup R&amp;D costs yet retail price keep increase is not right."},{"id":5808847,"gmtCreate":1631200753939,"gmtModify":1631200753939,"authorId":9000000000000155,"author":{"id":9000000000000155,"idStr":"9000000000000155","authorId":9000000000000155,"name":"来一口汤","avatar":"https://static.tigerbbs.com/3f5b3247f3d101bc688415312055ee08","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883947999,"type":1,"supId":0,"prevId":0,"content":"研发就是最大的支出，之前想不通为什么一些靶向药那么贵，后来看了一些文章才知道研发的费用都是天文数字。","text":"研发就是最大的支出，之前想不通为什么一些靶向药那么贵，后来看了一些文章才知道研发的费用都是天文数字。","html":"研发就是最大的支出，之前想不通为什么一些靶向药那么贵，后来看了一些文章才知道研发的费用都是天文数字。"},{"id":5808556,"gmtCreate":1631199437580,"gmtModify":1631199437580,"authorId":3479274822738867,"author":{"id":3479274822738867,"idStr":"3479274822738867","authorId":3479274822738867,"name":"路人丙钉钉","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883947999,"type":1,"supId":0,"prevId":0,"content":"每一次修改对于药企而言都是伤筋动骨的，他们也必然会想尽办法规避这种风险，毕竟收回研发成本才是第一位的","text":"每一次修改对于药企而言都是伤筋动骨的，他们也必然会想尽办法规避这种风险，毕竟收回研发成本才是第一位的","html":"每一次修改对于药企而言都是伤筋动骨的，他们也必然会想尽办法规避这种风险，毕竟收回研发成本才是第一位的"}],"langContent":"EN"},{"id":883955816,"gmtCreate":1631197939835,"gmtModify":1631889780583,"author":{"id":"4089463306606890","authorId":"4089463306606890","name":"AxelOng","avatar":"https://static.tigerbbs.com/8eaa7b50259b0329b74e09bc501ecd38","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4089463306606890","authorIdStr":"4089463306606890"},"htmlText":"If u control the price there will be not motivation to spend money in r n d. No good for research&nbsp;","listText":"If u control the price there will be not motivation to spend money in r n d. No good for research&nbsp;","text":"If u control the price there will be not motivation to spend money in r n d. No good for research","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883955816","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5808210,"gmtCreate":1631198020753,"gmtModify":1631889780592,"authorId":3574122255023758,"author":{"id":3574122255023758,"idStr":"3574122255023758","authorId":3574122255023758,"name":"JamesArthur","avatar":"https://static.tigerbbs.com/0230d592c84aee6b78c6136a020bbb52","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883955816,"type":1,"supId":0,"prevId":0,"content":"Agree to the max","text":"Agree to the max","html":"Agree to the max"}],"langContent":"EN"},{"id":883925892,"gmtCreate":1631197562316,"gmtModify":1631891165724,"author":{"id":"3580123620847057","authorId":"3580123620847057","name":"Wheee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3580123620847057","authorIdStr":"3580123620847057"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883925892","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5808270,"gmtCreate":1631198244296,"gmtModify":1634804228884,"authorId":3577352301253695,"author":{"id":3577352301253695,"idStr":"3577352301253695","authorId":3577352301253695,"name":"D199991D","avatar":"https://static.tigerbbs.com/49e24e0e3faeb8d389ad5d2db8a0e240","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883925892,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5810882,"gmtCreate":1631229174040,"gmtModify":1634804030548,"authorId":3567307840510045,"author":{"id":3567307840510045,"idStr":"3567307840510045","authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883925892,"type":1,"supId":0,"prevId":0,"content":"hi. please like and comment back. thank you.","text":"hi. please like and comment back. thank you.","html":"hi. please like and comment back. thank you."}],"langContent":"EN"},{"id":883926285,"gmtCreate":1631197468247,"gmtModify":1631890127112,"author":{"id":"3585252654864862","authorId":"3585252654864862","name":"SiewWeng","avatar":"https://static.tigerbbs.com/53df5a10f848dd9d79558c4f7a3fb9f8","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3585252654864862","authorIdStr":"3585252654864862"},"htmlText":"Yay","listText":"Yay","text":"Yay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883926285","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883928227,"gmtCreate":1631197407669,"gmtModify":1631889146922,"author":{"id":"3572529600057361","authorId":"3572529600057361","name":"Ygh","avatar":"https://static.tigerbbs.com/09f51a5273fd07aa4765ea2a333521d1","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3572529600057361","authorIdStr":"3572529600057361"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883928227","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5808087,"gmtCreate":1631197474892,"gmtModify":1631889146921,"authorId":3585252654864862,"author":{"id":3585252654864862,"idStr":"3585252654864862","authorId":3585252654864862,"name":"SiewWeng","avatar":"https://static.tigerbbs.com/53df5a10f848dd9d79558c4f7a3fb9f8","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883928227,"type":1,"supId":0,"prevId":0,"content":"Hey","text":"Hey","html":"Hey"}],"langContent":"EN"},{"id":883928961,"gmtCreate":1631197382853,"gmtModify":1632884003789,"author":{"id":"3562413816387860","authorId":"3562413816387860","name":"firstfruits","avatar":"https://static.tigerbbs.com/10628f9c1ecd1b1ed688fe5c74ad3511","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3562413816387860","authorIdStr":"3562413816387860"},"htmlText":"generic and biosimilar should be advantaged by this policy","listText":"generic and biosimilar should be advantaged by this policy","text":"generic and biosimilar should be advantaged by this policy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/883928961","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5812860,"gmtCreate":1631236021942,"gmtModify":1634803850305,"authorId":3570623270313531,"author":{"id":3570623270313531,"idStr":"3570623270313531","authorId":3570623270313531,"name":"joshc","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883928961,"type":1,"supId":0,"prevId":0,"content":"generics and biosimilar makers FTW","text":"generics and biosimilar makers FTW","html":"generics and biosimilar makers FTW"}],"langContent":"EN"},{"id":883923644,"gmtCreate":1631197292688,"gmtModify":1631889779722,"author":{"id":"4087968261291200","authorId":"4087968261291200","name":"Gyawh","avatar":"https://static.tigerbbs.com/b7e98e2fe85754b609a26fc86ffd7b82","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"4087968261291200","authorIdStr":"4087968261291200"},"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883923644","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883923846,"gmtCreate":1631197287485,"gmtModify":1631891953328,"author":{"id":"3586416730091306","authorId":"3586416730091306","name":"Gladys12345","avatar":"https://static.tigerbbs.com/8c9e9a64e6e530eabc1c7af92859e0a7","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3586416730091306","authorIdStr":"3586416730091306"},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/883923846","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5808117,"gmtCreate":1631197587141,"gmtModify":1631891953368,"authorId":3580123620847057,"author":{"id":3580123620847057,"idStr":"3580123620847057","authorId":3580123620847057,"name":"Wheee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883923846,"type":1,"supId":5808059,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":5808114,"gmtCreate":1631197571550,"gmtModify":1631891953356,"authorId":4090810527054110,"author":{"id":4090810527054110,"idStr":"4090810527054110","authorId":4090810527054110,"name":"St1143","avatar":"https://static.tigerbbs.com/c371329fac0ebdfc2f72b724292a0763","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883923846,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5808059,"gmtCreate":1631197350457,"gmtModify":1631891953341,"authorId":3576803977335172,"author":{"id":3576803977335172,"idStr":"3576803977335172","authorId":3576803977335172,"name":"HueiKwang","avatar":"https://static.tigerbbs.com/0b383f4a30ca6333c52769097600ed0b","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883923846,"type":1,"supId":0,"prevId":0,"content":"Liked","text":"Liked","html":"Liked"},{"id":5808040,"gmtCreate":1631197303194,"gmtModify":1631891953330,"authorId":4087968261291200,"author":{"id":4087968261291200,"idStr":"4087968261291200","authorId":4087968261291200,"name":"Gyawh","avatar":"https://static.tigerbbs.com/b7e98e2fe85754b609a26fc86ffd7b82","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883923846,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":883920440,"gmtCreate":1631197182980,"gmtModify":1631891006479,"author":{"id":"3575152525326279","authorId":"3575152525326279","name":"Bll","avatar":"https://static.tigerbbs.com/b372fc92d67296f5ba36af78d1d6e935","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3575152525326279","authorIdStr":"3575152525326279"},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/883920440","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5808078,"gmtCreate":1631197421435,"gmtModify":1631891006494,"authorId":3572529600057361,"author":{"id":3572529600057361,"idStr":"3572529600057361","authorId":3572529600057361,"name":"Ygh","avatar":"https://static.tigerbbs.com/09f51a5273fd07aa4765ea2a333521d1","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883920440,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5808037,"gmtCreate":1631197294279,"gmtModify":1631891006479,"authorId":3586416730091306,"author":{"id":3586416730091306,"idStr":"3586416730091306","authorId":3586416730091306,"name":"Gladys12345","avatar":"https://static.tigerbbs.com/8c9e9a64e6e530eabc1c7af92859e0a7","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":883920440,"type":1,"supId":0,"prevId":0,"content":"Please like","text":"Please like","html":"Please like"}],"langContent":"EN"},{"id":883967690,"gmtCreate":1631197119810,"gmtModify":1631883770870,"author":{"id":"3582457483215828","authorId":"3582457483215828","name":"Degenerated","avatar":"https://static.tigerbbs.com/fcad9a3e2865b545e3a1f4ec2cc9917a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582457483215828","authorIdStr":"3582457483215828"},"htmlText":"Drop more. I want to buu pfizer","listText":"Drop more. I want to buu pfizer","text":"Drop more. I want to buu pfizer","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883967690","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","LLY":"礼来","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"JNJ":0.9,"PFE":0.9,"LLY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":202,"commentSize":20,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}